Trials / Completed
CompletedNCT05323370
Lymphangioleiomyomatosis, a Study on Cathepsin K
Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a physiopathological case-control, non-interventional, monocentric study of adult patients with lymphangioleiomyomatosis. The controls are patients followed in neurology at the CHU of Tours for a tuberous sclerosis complex without lymphangioleiomyomatosis, the healthy volunteers are women with neither pulmonary nor renal pathology and recruited at the clinical investigation centre of the CHU of Tours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 24h urine | Urine samples will be collected at home over 24 hours |
| OTHER | urine sample | A urine sample of 20cc will be collected |
Timeline
- Start date
- 2022-05-31
- Primary completion
- 2022-10-30
- Completion
- 2022-10-30
- First posted
- 2022-04-12
- Last updated
- 2023-03-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05323370. Inclusion in this directory is not an endorsement.